Tryptophan via serotonin/kynurenine pathways abnormalities in a large cohort of aggressive inmates: markers for aggression

Aggressive behavior is one of the most challenging symptoms in psychiatry, and biological markers for aggression lack of large sample validations. Serotonin (5-HT) and other neuroactive compounds deriving from Tryptophan (Trp), including kynurenine (Kyn), have not yet been investigated in large cohorts of aggressive individuals to validate their potential as biomarkers of aggression. In 361 male inmates we measured serum levels of Trp, 5-hydroxytryptophan, 5-HT, Kyn, the ratios 5-HT/Trp∗1000 and Kyn/Trp∗1000, and performed Structured Clinical Interview for DSM-IV Axis-I and -II Disorders (SCID-I and -II), global assessment of functioning (GAF), and scales for aggressive behavior, impulsivity, adult attention-deficit/hyperactivity disorder (ADHD), and intelligent quotient (IQ). Aggressive compared to non-aggressive inmates exhibited lower Trp and Kyn serum levels but higher levels of 5-HT and 5-HT/Trp∗1000, higher levels of impulsivity and ADHD indices, lower IQ and GAF, higher prevalence of mood disorders, drug abuse/dependence, and borderline, conduct and antisocial behaviors. Interestingly, Kyn/Trp∗1000 was positively correlated to the number of severe aggressive acts (r=0.593, P<0.001). After adjusting for confounding factors, logistic regression analysis indicated that 5-HT/Trp∗1000, antisocial behavior, and GAF were predictors of aggressive behavior. The model combining these three predictors had an area under the ROC curve of 0.851 (95% CI 0.806-0.895). This study indicates that while circulating Trp is reduced in aggressive individuals, the combination of biological (5-HT/Trp ratio) and psychopathological (antisocial behavior and GAF) markers discriminates between aggressive and non-aggressive behavior suggesting the potential of a multi-marker approach in psychiatry given the heterogenic nature of mental diseases.

[1]  C. Benkelfat,et al.  Behavioral disinhibition induced by tryptophan depletion in nonalcoholic young men with multigenerational family histories of paternal alcoholism. , 1999, The American journal of psychiatry.

[2]  Frederick K. Goodwin,et al.  Aggression in humans correlates with cerebrospinal fluid amine metabolites , 1979, Psychiatry Research.

[3]  S. D. de Boer,et al.  5-HT1A and 5-HT1B receptor agonists and aggression: a pharmacological challenge of the serotonin deficiency hypothesis. , 2005, European journal of pharmacology.

[4]  A. Bond,et al.  The effect of tryptophan depletion and enhancement on subjective and behavioural aggression in normal male subjects , 1995, Psychopharmacology.

[5]  R. Schwarcz,et al.  Blood–Brain Barrier Transport of Kynurenines: Implications for Brain Synthesis and Metabolism , 1991, Journal of neurochemistry.

[6]  S. Fazel,et al.  Severe mental illness in 33,588 prisoners worldwide: systematic review and meta-regression analysis. , 2012, The British journal of psychiatry : the journal of mental science.

[7]  S. Leucht,et al.  Personality disorders and violence , 2008 .

[8]  L. Siever Neurobiology of aggression and violence. , 2008, The American journal of psychiatry.

[9]  D. Wechsler The Measurement Of Adult Intelligence , 1925 .

[10]  R. Wurtman,et al.  Brain Serotonin Content: Physiological Dependence on Plasma Tryptophan Levels , 1971, Science.

[11]  D. Nutt,et al.  Acute Tryptophan Depletion. Part I: Rationale and Methodology , 2005, The Australian and New Zealand journal of psychiatry.

[12]  R. O’Brien,et al.  A Caution Regarding Rules of Thumb for Variance Inflation Factors , 2007 .

[13]  G. Guillemin,et al.  Kynurenine Pathway Metabolites in Humans: Disease and Healthy States , 2009, International journal of tryptophan research : IJTR.

[14]  W. Castelli,et al.  Epidemiology of coronary heart disease: the Framingham study. , 1984, The American journal of medicine.

[15]  E. Coccaro,et al.  Impulsive aggression and central serotonergic system function in humans: an example of a dimensional brain‐behavior relationship , 1992, International clinical psychopharmacology.

[16]  Yong-Ku Kim,et al.  Network beyond IDO in psychiatric disorders: Revisiting neurodegeneration hypothesis , 2014, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[17]  D. Nutt,et al.  Acute Tryptophan Depletion. Part II: Clinical Effects and Implications , 2005 .

[18]  E. Coccaro,et al.  Etiology of the impulsivity/aggression relationship: Genes or environment? , 1999, Psychiatry Research.

[19]  G. Lawton THE MEASUREMENT OF ADULT INTELLIGENCE , 1939 .

[20]  S. Närvänen,et al.  Plasma insulin, tryptophan and serotonin levels during the glucose tolerance test among habitually violent and impulsive offenders. , 1987, Neuropsychobiology.

[21]  S. Young,et al.  Clinical response of aggressive schizophrenics to oral tryptophan. , 1983, Biological psychiatry.

[22]  B. Muthén,et al.  Developmental epidemiological courses leading to antisocial personality disorder and violent and criminal behavior: effects by young adulthood of a universal preventive intervention in first- and second-grade classrooms. , 2008, Drug and alcohol dependence.

[23]  F. Barale,et al.  Aggression in psychiatry wards: A systematic review , 2011, Psychiatry Research.

[24]  M. First,et al.  User's guide for the structured clinical interview for DSM-IV axis I disorders : SCID-I : clinical version , 1997 .

[25]  J. Tiihonen,et al.  Total plasma l‐tryptophan, free l‐tryptophan and competing amino acid levels in a homicidal male adolescent with conduct disorder , 2003, Acta psychiatrica Scandinavica.

[26]  G. Turecki,et al.  The neurodevelopmental origins of suicidal behavior , 2012, Trends in Neurosciences.

[27]  A. Convit,et al.  Tryptophan treatment of aggressive psychiatric inpatients , 1990, Biological Psychiatry.

[28]  R. Tremblay,et al.  Monoamine oxidase a gene promoter methylation and transcriptional downregulation in an offender population with antisocial personality disorder , 2015, British Journal of Psychiatry.

[29]  Organización Mundial de la Salud The World Report on violence and health , 2003 .

[30]  T. Poynard,et al.  Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study , 2001, The Lancet.

[31]  S. Stahl,et al.  Hyperserotonemia and amine metabolites in autistic and retarded children. , 1977, Archives of general psychiatry.

[32]  W. J. Klein,et al.  Aggression, suicide, and serotonin: relationships to CSF amine metabolites. , 1982, The American journal of psychiatry.

[33]  M. Virkkunen,et al.  Aggression, suicidality, and serotonin. , 1992, The Journal of clinical psychiatry.

[34]  S. Comai,et al.  The Psychopharmacology of Aggressive Behavior: A Translational Approach Part 1 Neurobiology , 2012, Journal of clinical psychopharmacology.

[35]  N. Schork,et al.  Understanding and predicting suicidality using a combined genomic and clinical risk assessment approach , 2015, Molecular Psychiatry.

[36]  John Danesh,et al.  Serious mental disorder in 23000 prisoners: a systematic review of 62 surveys. , 2002, Lancet.

[37]  R. Schwarcz,et al.  Kynurenines in the mammalian brain: when physiology meets pathology , 2012, Nature Reviews Neuroscience.

[38]  C. Benkelfat,et al.  Tryptophan Depletion, Executive Functions, and Disinhibition in Aggressive, Adolescent Males , 1998, Neuropsychopharmacology.

[39]  J. Epstein,et al.  Self-ratings of ADHD symptoms in adults I: Factor structure and normative data , 1999 .

[40]  K. Lesch,et al.  Targeting brain serotonin synthesis: insights into neurodevelopmental disorders with long-term outcomes related to negative emotionality, aggression and antisocial behaviour , 2012, Philosophical Transactions of the Royal Society B: Biological Sciences.

[41]  P. Donnelly,et al.  Relationship between ADHD symptoms and anti-social behaviour in a sample of older youths in adult Scottish prisons , 2014 .

[42]  M. First,et al.  Structured clinical interview for DSM-IV axis II personality disorders : SCID-II , 1997 .

[43]  K. Belendiuk,et al.  Tryptophan metabolism in children with attentional deficit disorder. , 1981, The American journal of psychiatry.

[44]  A. Maden Rethinking Risk Assessment. The MacArthur study of Mental Disorder and Violence , 2003 .

[45]  K. Belendiuk,et al.  Blood tryptophan metabolism in chronic schizophrenics. , 1981, Archives of general psychiatry.

[46]  S. Comai,et al.  The Psychopharmacology of Aggressive Behavior: A Translational Approach Part 2 Clinical Studies Using Atypical Antipsychotics, Anticonvulsants, and Lithium , 2012, Journal of clinical psychopharmacology.

[47]  Phil A. Silva,et al.  Whole Blood Serotonin Relates to Violence in an Epidemiological Study , 1998, Biological Psychiatry.

[48]  J. Tiihonen,et al.  Free L-tryptophan plasma levels in antisocial violent offenders , 2001, Psychopharmacology.

[49]  P. Appelbaum Public safety, mental disorders, and guns. , 2013, JAMA psychiatry.

[50]  J. Monahan,et al.  Violence by people discharged from acute psychiatric inpatient facilities and by others in the same neighborhoods. , 1998, Archives of general psychiatry.

[51]  V. Gabbay,et al.  The role of the kynurenine pathway in suicidality in adolescent major depressive disorder , 2015, Psychiatry Research.

[52]  R. Fontana,et al.  Changes in Mood States and Biomarkers During Peginterferon and Ribavirin Treatment of Chronic Hepatitis C , 2008, The American Journal of Gastroenterology.

[53]  R. Conroy,et al.  Lethality of suicide attempt rating scale. , 1984, Suicide & life-threatening behavior.

[54]  E. Ragazzi,et al.  Effects of PEG-interferon alpha plus ribavirin on tryptophan metabolism in patients with chronic hepatitis C. , 2011, Pharmacological research.

[55]  J. Horáček,et al.  Biochemical, Histopathological and Morphological Profiling of a Rat Model of Early Immune Stimulation: Relation to Psychopathology , 2015, PloS one.